DrugDashboards

Epinephrine

Epinephrine · EPINEPHRINE .1 mg/mL · Injection · Intravenous · International Medication Systems, Limited

NDC 76329-3318-01 · 10 CARTON in 1 PACKAGE / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGE · NDA · View full market →

The short version

25 companies supply this market — deep enough that no single failure threatens the supply. The price is up 9% over the past year, to $1.23 per mL. A Class II recall hit this product in the past year (International Medication Systems Ltd.). One of its named manufacturing plants, International Medication Systems, Ltd., failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: worth watching — several of the pressures that precede supply trouble are present at once. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.23per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$99.63per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$95.48per package of 10X10MLAmphastar Pharmaceuticals, Inc. · Mar 15, 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50May 2024Sep 2026$1.23
23 price points · per MLSource: CMS NADAC

Estimated fill cost

Estimated WAC per mLestimate
$1.264
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Medicaid spend (2025)

$48,521
1,735 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

25Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • Class I/II recall in past 12 months+15
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for epinephrine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $206.21 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA211363
TE code
Approval date
Aug 15, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingApr 1, 2026
    International Medication Systems Ltd.Lack of Assurance of Sterility

Manufacturers of Epinephrine (Injection)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE 1 mg/mLJul 23, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
Par Health USA, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 3, 2026
Remedyrepack Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
American Regent, Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals Private LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
BPI Labs, LLCEPINEPHRINE 30 mg/30mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Novo Nordisk Production Belgium SAEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Redpharm DrugEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Sina Health IncEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.EPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Epinephrine — NDC 76329-3318-01," retrieved September 3, 2026, https://drugdashboards.com/drug/76329331801.

Free to cite with attribution — see how the data is put together.